HuagongsheHuagongshe Chemistry Print Report · For research reference only
Upacicalcet → (2S)-2-amino-3-{[(3-sulfophenyl)carbamoyl]amino}propanoic acid
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Upacicalcet | HCID 53374467 | — |
| Reactant | (2S)-2-amino-3-{[(3-chloro-4-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid | HCID 53374468 | — |
| Reactant | (2S)-2-amino-3-{[(5-chloro-2-hydroxy-3-sulfophenyl)carbamoyl]amino}propanoic acid | HCID 53377991 | — |
| Product | (2S)-2-amino-3-{[(3-sulfophenyl)carbamoyl]amino}propanoic acid | HCID 88905973 | — |
Reaction Steps
Above all, (2S)-2-amino-3-{[(5-chloro-2-hydroxy-3-sulfophenyl)carbamoyl]amino}propanoic acid, (2S)-2-amino-3-{[(3-chloro-4-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid and (2S)-2-amino-3-{[(3-chloro-2-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid, or salts thereof, are particularly preferable as a compound that is used as a prophylactic or therapeutic agent for diabetes or obesity of the present invention.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09150505B2 |
| Source dataset | uspto-grants-2015_10 |
| ORD ID | ord-1714fe2ef09448f180336f8a64e377f4 |
| Source note | uspto-grants-2015_10 |